Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-04-21

Clinical Trial Update: SEvoflurane for Sedation in ARds [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating sevoflurane as a sedative in acute respiratory distress syndrome has completed. The study was sponsored by University Hospital, Clerm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sevoflurane (Sevoflurane)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Acute Respiratory Distress Syndrome | Phase 3 | Status: COMPLETED